Swedish healthtech startup Tandem has raised $100 million in a Series B funding round led by the European Union's €5 billion Scaleup Fund, the company announced today. Existing investors including Kinnevik, Northzone, Amino Collective, and Visionaries also participated in the round. Tandem’s technology is currently used by over 10,000 healthcare organisations across Europe.
The funding round was spearheaded by the EU Scaleup Fund, which aims to support high-growth European companies. Tandem’s existing backers Kinnevik, Northzone, Amino Collective, and Visionaries joined the round, demonstrating continued confidence in the startup’s growth trajectory. The company plans to use the fresh capital to expand its platform and increase adoption among healthcare providers.
This $100 million raise marks one of the largest healthtech funding rounds in Europe this year, highlighting growing investor interest in digital healthcare solutions. Tandem’s platform, which streamlines healthcare workflows and patient management, competes with other European healthtech firms that have recently secured significant funding. The EU Scaleup Fund’s involvement underscores the bloc’s commitment to fostering innovation in the healthcare sector.
Tandem currently serves more than 10,000 healthcare organisations, according to the company. The fresh capital injection will support its expansion efforts and product development, with further updates expected in the company’s next quarterly report scheduled for November 2026.